US2004096956A1PendingUtilityA1
Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
Priority: Jan 11, 1990Filed: Oct 20, 2003Published: May 20, 2004
Est. expiryJan 11, 2010(expired)· nominal 20-yr term from priority
C12N 15/10A61K 38/00C12N 15/102C07K 2319/00C07K 16/00
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of producing libraries of genes encoding antigen-combining molecules or antibodies is described. In addition, a method of producing antigen-combining molecules which does not require an in vivo procedure is described. Vectors useful in the present method and antigen-combining molecules produced by the method are discussed. The antigen-combining molecules are useful for the detection, quantitation, purification and neutralization of antigens, as well as for diagnostic, therapeutic and prophylactic purposes.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A host cell producing a DNA encoding an antigen-combining protein produced by the method of:
providing DNA containing genes encoding antigen-combining proteins; inserting said DNA into a framework antibody vector; and introducing said DNA and antibody framework vector into a host cell.
2 . The host cell of claim 1 , wherein the host cell is prokaryotic.
3 . The host cell of claim 1 , wherein the host cell is eukaryotic.
4 . The host cell of claim 3 , wherein the host cell is an immortalized cultured mammalian cell.
5 . The host cell of claim 4 , wherein the immortalized cultured mammalian cell is a myeloma or plasmacytoma cell.
6 . The host cell of Claim 1 wherein said DNA is introduced into the host cell by a method selected from the group consisting of: electroporation, calcium phosphate coprecipitation, protoplast fusion, viral infection, and cell fusion.
7 . The host cell of claim 1 , wherein the DNA containing genes encoding antigen-combining proteins encodes an antigen-combining protein selected from the group consisting of:
an immunoglobulin heavy chain variable region and an immunoglobulin light chain variable region.
8 . The host cell of claim 1 , wherein the antigen-combining proteins comprise antibodies.
9 . Host cells producing antibodies, produced by a method comprising:
providing DNA comprising genes encoding antibodies; inserting the DNA into framework antibody vectors; and introducing said framework antibody vectors into host cells.
10 . The host cells of claim 9 , wherein said DNA comprises a vector.
11 . The host cells of claim 10 , wherein said vector is an expression vector.
12 . The host cells of claim 9 , wherein the host cells are prokaryotic.
13 . The host cells of claim 9 , wherein the host cells are eukaryotic.
14 . The host cells of claim 13 , wherein the host cells are an immortalized cultured mammalian cell line.
15 . The host cells of claim 14 , wherein the immortalized cultured mammalian cell line is a myeloma or plasmacytoma cell line.
16 . The host cells of claim 9 , wherein said DNA is introduced into the host cells by a method selected from the group consisting of: electroporation, calcium phosphate coprecipitation, protoplast fusion, viral infection, and cell fusion.
17 . The host cells of claim 9 , wherein the DNA containing genes encoding antibodies encodes immunoglobulin heavy chain variable regions or immunoglobulin light chain variable regions.Join the waitlist — get patent alerts
Track US2004096956A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.